Menu Search
Equities

Option Care Health Inc

  • Add to watchlist
  • Add to portfolio
  • Add an alert
MM6A:FRA

Option Care Health Inc

Actions
  • Price (EUR)27.20
  • Today's Change-0.20 / -0.73%
  • Shares traded200.00
  • 1 Year change-8.72%
  • Beta0.8440
Data delayed at least 15 minutes, as of Feb 11 2026 07:02 GMT.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

Option Care Health, Inc. is an independent provider of home and alternate site infusion services. The Company’s infusion services include the clinical management of infusion therapy, nursing support and care coordination. It provides a therapy portfolio through its network of 92 full-service pharmacies and 93 stand-alone ambulatory infusion suites. It administers a wide variety of therapies and services, including anti-infectives infusion, nutrition support, immunoglobulin infusion, chronic inflammatory disorders, neurological disorders, bleeding disorders infusion, Naven health, women’s health, heart failure, and others. Its home infusion services include medication and supplies for administration and use at home or within one of its ambulatory infusion suites, consultation and education regarding the patient’s condition and the prescribed medication nursing support, clinical monitoring and assistance in monitoring potential side effects, and assistance in obtaining reimbursement.

  • Revenue in USD (TTM)5.53bn
  • Net income in USD209.21m
  • Incorporated1996
  • Employees6.02k
  • Location
    Option Care Health Inc3000 Lakeside Dr, Suite 300NBANNOCKBURN 60015United StatesUSA
  • Phone+1 (312) 940-2443
  • Fax+1 (302) 636-5454
  • Websitehttps://optioncarehealth.com/
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.